_____ is the most recent advancement in radiopharmaceutical therapy that has shown to be effective in metastatic prostate patients. 

Which of the following is a disadvantage to using preoperative RT to treat STS? 

Lymphatic spread is only a concern in primary bone cancers when it arises in the ____.

The majority of soft tissue sarcomas are found in the:

A dose of ___ is typically given postoperatively to patients with Ewing sarcoma. 

Melphalan is the most common chemotherapy agent used to treat chondrosarcomas. 

The most common pathologic fracture results from metastatic prostate cancer.

uint64_t get(void* p){   return [data];}

____ is characterized by rapid aging and is associated with an increased risk for developing a soft tissue sarcoma.

Multiple myeloma peaks in the ___ decade(s).